Safety of Vitamin D Replacement in Patients with Primary Hyperparathyroidism and Concomitant Vitamin D Deficiency
- 1 May 2013
- journal article
- Published by Elsevier BV in Endocrine Practice
- Vol. 19 (3), 420-425
- https://doi.org/10.4158/ep12155.or
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A case–control study of ultraviolet radiation exposure, vitamin D, and lymphoma risk in adultsCancer Causes & Control, 2010
- Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International WorkshopJournal of Clinical Endocrinology & Metabolism, 2009
- Vitamin D deficiency and primary hyperparathyroidism: An association of uncertain cause and consequencesSurgery, 2008
- Impact of 25-Hydroxyvitamin D Deficiency on Perioperative Parathyroid Hormone Kinetics and Results in Patients with Primary HyperparathyroidismSurgery, 2007
- Vitamin D Deficiency and Primary HyperparathyroidismJournal of Bone and Mineral Research, 2007
- A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidismJournal of Endocrinological Investigation, 2006
- Correlations between Vitamin D Status and Biochemical/Clinical and Pathological Parameters in Primary HyperparathyroidismWorld Journal of Surgery, 2006
- The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient regionJournal of Endocrinological Investigation, 2004
- Hypovitaminosis D in Medical InpatientsThe New England Journal of Medicine, 1998
- The role of 1,25‐dihydroxyvitamin D in the mechanism of acquired vitamin D deficiencyClinical Endocrinology, 1992